Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda Nabben

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Physiology & Behavior|January 15, 2008
Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolismMiranda Nabben, Joris Hoeks
Cardiovascular Drugs and Therapy|June 18, 2016
GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk? : Editorial to: "The Impact of Chronic Glycogen Synthase Kinase-3 Inhibition on Remodeling of Normal and Pre-Diabetic Rat Hearts." by Barbara Huisamen et alMiranda Nabben, Dietbert Neumann
Nature Reviews. Cardiology|October 28, 2018
Metabolic remodelling in heart failure revisitedMiranda Nabben, Joost J F P Luiken, Jan F C Glatz
Current Opinion in Lipidology|February 7, 2022
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasisJan F C Glatz, Miranda Nabben, Joost J F P Luiken
Journal of Lipid and Atherosclerosis|August 22, 2020
CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac DysfunctionJan F C Glatz, Joost J F P Luiken, Miranda Nabben
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 27, 2020
Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistanceJoost J F P Luiken, Miranda Nabben, Dietbert Neumann, et al.
Circulation Research|May 9, 2015
Letter by Neumann et al regarding article, "Myostatin regulates energy homeostasis in the heart and prevents heart failure"Dietbert Neumann, Joost J F P Luiken, Miranda Nabben, et al.
Expert Opinion on Therapeutic Targets|June 15, 2021
CD36 as a target for metabolic modulation therapy in cardiac diseaseJan F C Glatz, Fang Wang, Miranda Nabben, et al.
Current Heart Failure Reports|May 27, 2022
Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and HealthMyrthe M A Willemars, Miranda Nabben, Job A J Verdonschot, et al.
Biochimica Et Biophysica Acta|September 13, 2016
Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptakeJoost J F P Luiken, Dipanjan Chanda, Miranda Nabben, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Physiology & Behavior|January 15, 2008
Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolismMiranda Nabben, Joris Hoeks
Cardiovascular Drugs and Therapy|June 18, 2016
GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk? : Editorial to: "The Impact of Chronic Glycogen Synthase Kinase-3 Inhibition on Remodeling of Normal and Pre-Diabetic Rat Hearts." by Barbara Huisamen et alMiranda Nabben, Dietbert Neumann
Nature Reviews. Cardiology|October 28, 2018
Metabolic remodelling in heart failure revisitedMiranda Nabben, Joost J F P Luiken, Jan F C Glatz
Current Opinion in Lipidology|February 7, 2022
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasisJan F C Glatz, Miranda Nabben, Joost J F P Luiken
Journal of Lipid and Atherosclerosis|August 22, 2020
CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac DysfunctionJan F C Glatz, Joost J F P Luiken, Miranda Nabben
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 27, 2020
Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistanceJoost J F P Luiken, Miranda Nabben, Dietbert Neumann, et al.
Circulation Research|May 9, 2015
Letter by Neumann et al regarding article, "Myostatin regulates energy homeostasis in the heart and prevents heart failure"Dietbert Neumann, Joost J F P Luiken, Miranda Nabben, et al.
Expert Opinion on Therapeutic Targets|June 15, 2021
CD36 as a target for metabolic modulation therapy in cardiac diseaseJan F C Glatz, Fang Wang, Miranda Nabben, et al.
Current Heart Failure Reports|May 27, 2022
Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and HealthMyrthe M A Willemars, Miranda Nabben, Job A J Verdonschot, et al.
Biochimica Et Biophysica Acta|September 13, 2016
Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptakeJoost J F P Luiken, Dipanjan Chanda, Miranda Nabben, et al.
Pageof 6